Волчанка: открытый доступ
Открытый доступ
ISSN: 2684-1630
ISSN: 2684-1630
Andrej Spec
Different treatments for lupus. It's an exciting time in lupus research says Dr. Richard Furie, chief of rheumatology at North well Health in New York. In today's one on one interview, he breaks down some of the lupus studies."It's an exciting time in lupus," Dr. Furie says. "The foray into lupus and lupus nephritis trials started in the early 1990s. The results of our efforts were just one drug and that was belimumab approved by the FDA about 10 years ago. But, it's not for lack of trying. It's just that lupus is incredibly challenging for a lot of different reasons. We're finally starting to see the light at the end of the tunnel in systemic lupus and also lupus nephritis.